CY1121415T1 - Βελτιωμενη μεθοδος για την ακυλιωση μεϋτανσινολης - Google Patents

Βελτιωμενη μεθοδος για την ακυλιωση μεϋτανσινολης

Info

Publication number
CY1121415T1
CY1121415T1 CY20191100302T CY191100302T CY1121415T1 CY 1121415 T1 CY1121415 T1 CY 1121415T1 CY 20191100302 T CY20191100302 T CY 20191100302T CY 191100302 T CY191100302 T CY 191100302T CY 1121415 T1 CY1121415 T1 CY 1121415T1
Authority
CY
Cyprus
Prior art keywords
amino acid
improved method
meyltansinol
achylation
methanesinol
Prior art date
Application number
CY20191100302T
Other languages
Greek (el)
English (en)
Inventor
Wayne C. Widdison
Robert Yongxin Zhao
Original Assignee
Immunogen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen, Inc. filed Critical Immunogen, Inc.
Publication of CY1121415T1 publication Critical patent/CY1121415T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16Peri-condensed systems
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01RELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R12/00Structural associations of a plurality of mutually-insulated electrical connecting elements, specially adapted for printed circuits, e.g. printed circuit boards [PCB], flat or ribbon cables, or like generally planar structures, e.g. terminal strips, terminal blocks; Coupling devices specially adapted for printed circuits, flat or ribbon cables, or like generally planar structures; Terminals specially adapted for contact with, or insertion into, printed circuits, flat or ribbon cables, or like generally planar structures
    • H01R12/50Fixed connections
    • H01R12/51Fixed connections for rigid printed circuits or like structures
    • H01R12/55Fixed connections for rigid printed circuits or like structures characterised by the terminals
    • H01R12/58Fixed connections for rigid printed circuits or like structures characterised by the terminals terminals for insertion into holes
    • H01R12/585Terminals having a press fit or a compliant portion and a shank passing through a hole in the printed circuit board
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00Printed circuits
    • H05K1/02Details
    • H05K1/0201Thermal arrangements, e.g. for cooling, heating or preventing overheating
    • H05K1/0203Cooling of mounted components
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00Printed circuits
    • H05K1/02Details
    • H05K1/11Printed elements for providing electric connections to or between printed circuits
    • H05K1/115Via connections; Lands around holes or via connections
    • H05K1/116Lands, clearance holes or other lay-out details concerning the surrounding of a via
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00Printed circuits
    • H05K1/18Printed circuits structurally associated with non-printed electric components
    • H05K1/181Printed circuits structurally associated with non-printed electric components associated with surface mounted components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY20191100302T 2012-09-26 2019-03-13 Βελτιωμενη μεθοδος για την ακυλιωση μεϋτανσινολης CY1121415T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261705731P 2012-09-26 2012-09-26
PCT/US2013/061839 WO2014052537A1 (en) 2012-09-26 2013-09-26 Improved methods for the acylation of maytansinol

Publications (1)

Publication Number Publication Date
CY1121415T1 true CY1121415T1 (el) 2020-05-29

Family

ID=49328648

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20191100302T CY1121415T1 (el) 2012-09-26 2019-03-13 Βελτιωμενη μεθοδος για την ακυλιωση μεϋτανσινολης
CY20211100594T CY1124337T1 (el) 2012-09-26 2021-07-02 Βελτιωμενες μεθοδοι για την ακυλιωση μεϋτανσινολης

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20211100594T CY1124337T1 (el) 2012-09-26 2021-07-02 Βελτιωμενες μεθοδοι για την ακυλιωση μεϋτανσινολης

Country Status (27)

Country Link
US (9) US9012629B2 (enExample)
EP (3) EP2900676B1 (enExample)
JP (7) JP6517693B2 (enExample)
CN (2) CN108586487B (enExample)
AU (4) AU2013323572B2 (enExample)
BR (2) BR122021022582B1 (enExample)
CA (2) CA2884873C (enExample)
CY (2) CY1121415T1 (enExample)
DK (2) DK2900676T3 (enExample)
ES (2) ES2716561T3 (enExample)
HR (2) HRP20190473T1 (enExample)
HU (2) HUE043285T2 (enExample)
IL (2) IL237899A (enExample)
LT (2) LT3486248T (enExample)
MX (2) MX366701B (enExample)
MY (1) MY169250A (enExample)
NZ (2) NZ739573A (enExample)
PL (2) PL3486248T3 (enExample)
PT (2) PT2900676T (enExample)
RS (2) RS58493B1 (enExample)
RU (2) RU2648992C2 (enExample)
SG (1) SG11201501918UA (enExample)
SI (2) SI2900676T1 (enExample)
SM (2) SMT201900170T1 (enExample)
TR (1) TR201903625T4 (enExample)
WO (1) WO2014052537A1 (enExample)
ZA (1) ZA201501898B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE043285T2 (hu) * 2012-09-26 2019-08-28 Immunogen Inc Javított eljárás maytansinol acilezésére
CN105585579A (zh) * 2014-10-24 2016-05-18 南京联宁生物制药有限公司 一种化合物及其制备方法以及美登素dm1的制备方法
AU2016233227B2 (en) 2015-03-17 2020-03-12 Regeneron Pharmaceuticals, Inc. Amino acid acylation reagents and methods of using the same
JP7350313B2 (ja) 2016-12-16 2023-09-26 ブルーフィン バイオメディシン, インコーポレイテッド 抗cubドメイン含有タンパク質1(cdcp1)抗体、抗体薬物コンジュゲート、およびその使用方法
PL3956332T3 (pl) 2019-04-18 2023-05-29 Indena S.P.A. Diastereoselektywny sposób wytwarzania estrów majtanzynoidowych zawierających tiol lub dwusiarczek i ich produkty pośrednie
EP4067497A4 (en) 2019-11-29 2024-03-13 MicroBiopharm Japan Co., Ltd. Method for enzymatically producing maytansinol

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151042A (en) 1977-03-31 1979-04-24 Takeda Chemical Industries, Ltd. Method for producing maytansinol and its derivatives
JPS6034556B2 (ja) * 1977-03-31 1985-08-09 武田薬品工業株式会社 抗生物質c−15003
US4137230A (en) 1977-11-14 1979-01-30 Takeda Chemical Industries, Ltd. Method for the production of maytansinoids
US4265814A (en) 1978-03-24 1981-05-05 Takeda Chemical Industries Matansinol 3-n-hexadecanoate
JPS5562090A (en) 1978-10-27 1980-05-10 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS5566585A (en) 1978-11-14 1980-05-20 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55164687A (en) 1979-06-11 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55162791A (en) 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
JPS55164685A (en) 1979-06-08 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55164686A (en) 1979-06-11 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
US4309428A (en) 1979-07-30 1982-01-05 Takeda Chemical Industries, Ltd. Maytansinoids
JPS5622790A (en) * 1979-07-31 1981-03-03 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS5645483A (en) 1979-09-19 1981-04-25 Takeda Chem Ind Ltd C-15003phm and its preparation
JP3054741B2 (ja) * 1989-09-29 2000-06-19 武田薬品工業株式会社 Tan―1313およびそのアシル誘導体
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
EP1229934B1 (en) * 1999-10-01 2014-03-05 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6441163B1 (en) 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
TWI298067B (en) * 2002-01-31 2008-06-21 Daiso Co Ltd New optically active compound, method for kinetic resolution of carbonic acid derivatives and catalyst thereof
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
PL1651162T3 (pl) * 2003-05-20 2016-04-29 Immunogen Inc Maitansynoidy w leczeniu nowotworów
CN1894259A (zh) * 2003-08-22 2007-01-10 活跃生物工艺学公司 利福霉素类似物及其应用
ES2579805T3 (es) 2004-09-23 2016-08-16 Genentech, Inc. Anticuerpos y conjugados modificados por ingeniería genética con cisteína
WO2006062779A2 (en) * 2004-12-09 2006-06-15 Centocor, Inc. Anti-integrin immunoconjugates, methods and uses
US7301019B2 (en) * 2005-01-21 2007-11-27 Immunogen, Inc. Method for the preparation of maytansinoid esters
WO2007011721A1 (en) * 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin
JP5167130B2 (ja) * 2005-08-09 2013-03-21 ミレニアム ファーマシューティカルズ, インコーポレイテッド キラルアミノ酸を有するメイタンシノールのアシル化方法
US20090082386A1 (en) * 2006-11-06 2009-03-26 Erzsebet Meszarosne Sos Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
JP2008288289A (ja) 2007-05-16 2008-11-27 Oki Electric Ind Co Ltd 電界効果トランジスタとその製造方法
ME03479B (me) 2009-06-03 2020-01-20 Immunogen Inc Metodi konjugacije
WO2011051960A2 (en) * 2009-09-25 2011-05-05 Cadila Healthcare Limited Process for the preparation of rapamycin derivatives
ES2544608T3 (es) * 2010-11-17 2015-09-02 Genentech, Inc. Conjugados de anticuerpo y de alaninil-maitansinol
HUE043285T2 (hu) * 2012-09-26 2019-08-28 Immunogen Inc Javított eljárás maytansinol acilezésére

Also Published As

Publication number Publication date
SMT202100390T1 (it) 2021-09-14
IL253988A0 (en) 2017-10-31
CA3133906A1 (en) 2014-04-03
PL2900676T3 (pl) 2019-06-28
JP2025098242A (ja) 2025-07-01
RU2648992C2 (ru) 2018-03-29
WO2014052537A1 (en) 2014-04-03
SMT201900170T1 (it) 2019-05-10
CN104768955A (zh) 2015-07-08
CN108586487B (zh) 2021-11-05
NZ706019A (en) 2018-03-23
JP2022068367A (ja) 2022-05-09
AU2013323572B2 (en) 2017-12-07
AU2018201392B2 (en) 2020-03-12
IL253988B (en) 2019-02-28
TR201903625T4 (tr) 2019-04-22
AU2022201557A1 (en) 2022-03-31
EP3486248B1 (en) 2021-04-07
US9796731B2 (en) 2017-10-24
US9012629B2 (en) 2015-04-21
HUE043285T2 (hu) 2019-08-28
SI3486248T1 (sl) 2021-10-29
CA2884873A1 (en) 2014-04-03
ES2716561T3 (es) 2019-06-13
LT2900676T (lt) 2019-03-25
US20140142297A1 (en) 2014-05-22
MY169250A (en) 2019-03-19
DK2900676T3 (en) 2019-04-08
HK1212341A1 (en) 2016-06-10
JP2016500657A (ja) 2016-01-14
AU2013323572A1 (en) 2015-04-02
ES2880754T3 (es) 2021-11-25
JP6735000B1 (ja) 2020-08-05
EP2900676A1 (en) 2015-08-05
JP2024010055A (ja) 2024-01-23
US10461449B2 (en) 2019-10-29
BR112015006505B1 (pt) 2022-03-15
AU2020203823A1 (en) 2020-07-02
MX366701B (es) 2019-07-22
ZA201501898B (en) 2019-06-26
NZ739573A (en) 2019-11-29
MX390615B (es) 2025-03-20
PT2900676T (pt) 2019-03-29
IL237899A (en) 2017-08-31
HUE055443T2 (hu) 2021-11-29
EP2900676B1 (en) 2018-12-19
SG11201501918UA (en) 2015-05-28
US20200153130A1 (en) 2020-05-14
PT3486248T (pt) 2021-07-12
BR112015006505A2 (pt) 2017-07-04
HRP20190473T1 (hr) 2019-05-03
JP2018109044A (ja) 2018-07-12
AU2018201392A1 (en) 2018-03-15
CN104768955B (zh) 2018-04-27
RU2765072C2 (ru) 2022-01-25
RS58493B1 (sr) 2019-04-30
MX2019008652A (es) 2019-09-13
US10944190B2 (en) 2021-03-09
CY1124337T1 (el) 2022-07-22
SI2900676T1 (sl) 2019-04-30
HRP20211030T1 (hr) 2021-10-01
JP2020117527A (ja) 2020-08-06
EP3486248A1 (en) 2019-05-22
US10100062B2 (en) 2018-10-16
BR122021022582B1 (pt) 2023-01-10
EP3904358A1 (en) 2021-11-03
US20190013604A1 (en) 2019-01-10
JP6517693B2 (ja) 2019-05-22
LT3486248T (lt) 2021-08-25
RU2015111635A (ru) 2016-11-20
AU2020203823B2 (en) 2021-12-09
US20150191488A1 (en) 2015-07-09
CA2884873C (en) 2021-11-23
CA3133906C (en) 2023-05-02
RS62075B1 (sr) 2021-07-30
US20240313444A1 (en) 2024-09-19
US20240145953A1 (en) 2024-05-02
US20180099980A1 (en) 2018-04-12
MX2015003745A (es) 2015-06-24
RU2018109295A3 (enExample) 2021-06-24
JP2020180150A (ja) 2020-11-05
DK3486248T3 (da) 2021-07-12
RU2018109295A (ru) 2019-02-26
US9469655B2 (en) 2016-10-18
PL3486248T3 (pl) 2021-10-25
US20250007192A1 (en) 2025-01-02
US20170137440A1 (en) 2017-05-18
CN108586487A (zh) 2018-09-28

Similar Documents

Publication Publication Date Title
CY1121415T1 (el) Βελτιωμενη μεθοδος για την ακυλιωση μεϋτανσινολης
CY1125155T1 (el) Κρυσταλλικες μορφες αναστολεα προλυλο υδροξυλασης
CY1122670T1 (el) Παρασκευη παρασκευασματος και παρασκευασμα που περιλαμβανει αναστολεα μεκ
CY1121129T1 (el) Αναστολεις toy fgfr4 πυριμιδινης
CY1121776T1 (el) C17-αλκανοδιυλιο και παραγωγα αλκενοδιυλιου του ολεανολικου οξεος και μεθοδοι χρησης αυτων
BR112014018756A8 (pt) Processo para preparo de etil éster de ácido n-(4-ciclo-hexil-3-trifluorometil-benziloxi)-acetimídico
CY1120397T1 (el) Amino αμιδια τυπου δενδριμερους που εχουν δραστικοτητα αναστολεα διαυλου νατριου για τη θεραπεια ξηρου οφθαλμου και αλλων βλεννογονικων ασθενειων
BR112015004111A2 (pt) novos derivados bicíclicos
BR112015031913A2 (pt) processo para a fabricação de amino-benzoxazinonas 4-propargilatadas e sua utilização
CY1118883T1 (el) Μεθοδος παρασκευης βορτιοξετινης
EA201500234A1 (ru) Способ получения бензоксазинонов
CY1118945T1 (el) Μεθοδος και ενδιαμεσα για την παρασκευη πρεγκαμπαλινης
BR112017028128A2 (pt) ?processo para a preparação de uma poliamida?
MX375447B (es) Proceso para fabricar haloacetamidas.
BR112017009876A2 (pt) processos e intermediários para a preparação de éteres de dialcano terminados em ácido alfa,ômega-dicarboxílico
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
CY1114493T1 (el) Διαδικασια για την παρασκευη μιας ενωσης χρησιμης ως αναστολεα της tafia
MX362371B (es) Proceso para preparar 2-metoximetil-1,4-bencenodiamina y sales de esta.
MX362691B (es) Proceso para preparar cloruros de 4-[[(benzoil)amino]sulfonil]benz oílo y preparación de acilsulfamoilbenzamidas.
TR201901398T4 (tr) Lakozamidi hazırlama işlemi.
MX2019006959A (es) Procesos para la preparacion de compuestos de pirimidinilciclopentano.
TR201907568T4 (tr) [5-floro-3-({2-[(4-florobenzen) sülfonil]piridin-3-il}metil)-2-metilindol-1-il]-asetik asidin polimorfik formu.
AR095548A1 (es) Preparación de ácido 4-amino-2,4-dioxobutanoico
EA201200756A1 (ru) Лиофилизат соединения бороновой кислоты
BR112014012595A2 (pt) processo de racemização de ácido (s)-3-carbamoilmetil-5-metil-hexanoico